MONDAY, Feb. 1, 2021 (HealthDay News) — The nerve pain drug gabapentin might reduce damage after a spinal cord injury, research in mice suggests. The drug prevented harmful structural changes in injured spinal cords, as well as cardiovascular changes and immune suppression caused by spinal cord injury, according to theContinue Reading
THURSDAY, Jan. 28, 2021 (HealthDay News) — Vitamin D is an essential nutrient, and recent research has suggested it may also help guard against severe COVID-19. But how much is enough, and how hard is it to get the right amount of vitamin D? “We know that a large percentageContinue Reading
MONDAY, Jan. 25, 2021 (HealthDay News) — Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers say. The new global analysis found that hospitalized patients with moderate COVID-19 may benefit from the drugs’ clot-preventing powers, but patients with illness soContinue Reading
MONDAY, Jan. 25, 2021 (HealthDay News) — Here’s one reason why past or current smoking may handicap you if you are battling breast cancer: New research suggests that nicotine promotes the spread of the disease to your lungs. Smoking is known to increase the risk that breast cancer will spread,Continue Reading
THURSDAY, Jan. 21, 2021 (HealthDay News) — The arthritis drug tocilizumab doesn’t help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early.Continue Reading
WEDNESDAY, Jan. 13, 2021 (HealthDay News) — New research offers a novel explanation for the long-term brain problems many COVID-19 patients experience. Many coronavirus patients report headaches and “brain fog” for weeks or months after they recover from respiratory symptoms. It’s been believed that these lingering neurological issues are theContinue Reading
MONDAY, Oct. 26, 2020 (HealthDay News) — When the new coronavirus pandemic first began, respiratory distress immediately became the hallmark of severe COVID-19 illness. News reports focused on the inability to breathe, low oxygen saturation levels and the alarming need for ventilators. But six months later, experts are becoming increasinglyContinue Reading
FRIDAY, Oct. 23, 2020 (HealthDay News) — High levels of a protein that lubricates the knee joint may actually be a harbinger of impending joint disease, a surprising animal study suggests. The researchers looked at the role of the protein, known as lubricin, in anterior cruciate ligament (ACL) injuries inContinue Reading
TUESDAY, Oct. 20, 2020 (HealthDay News) — About 30 million U.S. adults live with osteoarthritis and the pain and stiffness it causes, a new survey finds. And nearly one-third of these people said their symptoms are not well-managed, according to the Arthritis Foundation survey of almost 2,000 adults. In osteoarthritis,Continue Reading
MONDAY, Oct. 19, 2020 (HealthDay News) — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treatedContinue Reading